To include your compound in the COVID-19 Resource Center, submit it here.

BioInvent, Pfizer in cancer antibody deal

BioInvent International AB (SSE:BINV) gained SEK0.63 (32%) to SEK2.63 after announcing

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE